Timing of adverse events in patients undergoing acute and elective hip arthroplasty surgery: a multicentre cohort study using the Global Trigger Tool.
Martin MagnéliPaula Kelly-PetterssonCecilia RogmarkMax GordonOlof SköldenbergMaria UnbeckPublished in: BMJ open (2023)
A wide variability was found regarding the timing of different AEs with the majority occurring within 30 days. The timing and preventability varied regarding the severity. Most of the AEs were deemed to be preventable and/or of major severity. To increase patient safety for patients undergoing hip arthroplasty surgery, a better understanding of the multifaceted nature of the timing of AEs in relation to the occurrence of differing AEs is needed.
Keyphrases
- patients undergoing
- patient safety
- minimally invasive
- coronary artery bypass
- quality improvement
- liver failure
- adverse drug
- risk assessment
- total hip arthroplasty
- clinical trial
- emergency department
- intensive care unit
- acute coronary syndrome
- coronary artery disease
- cross sectional
- extracorporeal membrane oxygenation
- aortic dissection
- double blind
- percutaneous coronary intervention